Neehar Parikh is a Gastroenterology physician affiliated with University of Michigan. OpenAlex indexes 435 publications with 13,813 citations (h-index 60). By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
3rd Floor Taubman Center Recp D
Ann Arbor, MI 481095000
Telephone
734-647-5944Registry record last updated 31 Jul 2013.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sirtex Medical IncProgram year20252 payments
- Fujifilm Healthcare Americas CorporationProgram year20253 payments
- Exact Sciences CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.5%Bile Acid11%Ursodiol100%Part D<11 patientsCorticosteroid8.4%Prednisone100%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
35.7%Calcineurin inhibitor32%Tacrolimus57%Envarsus Xr30%Cyclosporine Modified13%Part D<11 patientsPurine Antimetabolite3.7%Azathioprine100%Part D<11 patientsCardiovascular
23.6%Loop diuretic10.5%Bumetanide63%Furosemide38%Part D<11 patientsAldosterone antagonist (MRA)7.1%Spironolactone100%Part D≥15 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Stakeholder Engagement and Modeling for Adoption of a Novel Cirrhosis Detection Algorithm
University of Michigan at Ann Arbor
FY2026$810,994R01DK142691 - Statin Therapy for patients with compensated Cirrhosis
University of Michigan at Ann Arbor
FY2026$610,662U01DK130113 - Statin Therapy for patients with compensated Cirrhosis
University of Michigan at Ann Arbor
FY2025$613,662U01DK130113
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Clinical and Molecular Hepatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”